Well, I hate to say this, but the US is coming into whats expected to be its worst time. So the number of patients in the "right" category presenting in trial sites, has been increasing dramatically. So - it should speed us to full enrollment.
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-64
-
- There are more pages in this discussion • 329 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.060(5.63%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.00 | $1.751M | 1.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 149750 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 41578 | 18 |
View Market Depth
| Last trade - 11.52am 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |